|
The company's legal name is Immune Modulation, Inc.; (IMI). IMI is a corporation organized for profit and existing under the laws of the State of Delaware and qualified to transact intrastate business in the State of California.
Corporate History
Management
Scientific Advisory Board
Consultants
Legal Representation
Corporate History
Immune Modulation, Incorporated (IMI) is an early development stage company conducting research and developing pharmaceutical drugs in the areas of transplanatation, inflammation, oncology, and virology.IMI was formed in 1995 based on the prior research of Dr. Emmanuel A. Ojo-Amaize. In 1996 the scope of IMI was expanded to include natural products from Africa. One such product is hypoestoxide, which has been found to possess potent anti-angiogenic, anti-viral, and anti-tumor activities
go to top of page
Management
(click on a name for that person's Bio)
Emmanuel A. Ojo-Amaize, Ph.D.
send a message
Co-founder, President & Chief Executive Officer
Howard B. Cottam, Ph.D.
send a message
Co-founder, Vice President
Emeka J. Nchekwube, M.D.
send a message
Medical Director
Olusola A. Oyemade, M.D., M.P.H.
send a message
Managing Director
Joseph I. Okogun, Ph.D.
Director General, IMI Nigeria, Ltd.
Anthony A. Tiongson, CPA, M.A.
Chief Financial Officer
go to top of page
Scientific Advisory Board
Clive R. Taylor, M.D., Ph.D.Professor and Chairman, Department of Pathology, University of Southern California School of Medicine, Los Angeles, Ca
Rishab K. Gupta, Ph.D.
Director, Immunodiagnosis, John Wayne Cancer Institute, Santa Monica, Ca. Formerly, Professor of Medicine, UCLA School of Medicine, Los Angeles, Ca
J. Edwin Seegmiller, M.D.
Professor of Medicine, Associate Director, Institute for Research on Aging. Department of Medicine, University of California, San Diego, Ca.
go to top of page
Consultants
Michael Karin, Ph.D.Professor of Pharmacology, Director, Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California, San Diego, California.
Judith A. Varner, Ph.D.
Assistant Professor of Medicine, Cancer Center, University of California, San Diego, California.
go to top of page
Legal Representation
IMI retains the services of Pillsbury Winthrop, LLP. , for corporate development, intellectual properties, strategic licensing and partnering transactions.go to top of page